These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 28107702)
1. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion. Yue D; Wang Y; Sun Y; Niu Y; Chang C Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702 [TBL] [Abstract][Full Text] [Related]
2. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis. Wang Y; Yue D; Xiao M; Qi C; Chen Y; Sun D; Zhang N; Chen R J Proteome Res; 2015 Feb; 14(2):804-13. PubMed ID: 25497084 [TBL] [Abstract][Full Text] [Related]
3. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis. Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087 [TBL] [Abstract][Full Text] [Related]
4. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status. Chen Y; Sun Y; Rao Q; Xu H; Li L; Chang C Oncotarget; 2015 Oct; 6(31):31203-15. PubMed ID: 26304926 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals. Wang K; Sun Y; Tao W; Fei X; Chang C Cancer Lett; 2017 May; 394():1-12. PubMed ID: 28089832 [TBL] [Abstract][Full Text] [Related]
6. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis. Gong D; Sun Y; Guo C; Sheu TJ; Zhai W; Zheng J; Chang C Clin Transl Med; 2021 Mar; 11(3):e353. PubMed ID: 33783995 [TBL] [Abstract][Full Text] [Related]
7. C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells. Wang Y; Fu D; Su J; Chen Y; Qi C; Sun Y; Niu Y; Zhang N; Yue D Sci Rep; 2017 Apr; 7(1):999. PubMed ID: 28428626 [TBL] [Abstract][Full Text] [Related]
8. The m Gong D; Zhang J; Chen Y; Xu Y; Ma J; Hu G; Huang Y; Zheng J; Zhai W; Xue W J Exp Clin Cancer Res; 2019 Jun; 38(1):233. PubMed ID: 31159832 [TBL] [Abstract][Full Text] [Related]
9. YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2. Cui Q; Wang C; Liu S; Du R; Tian S; Chen R; Geng H; Subramanian S; Niu Y; Wang Y; Yue D Cell Cycle; 2021 Nov; 20(22):2413-2427. PubMed ID: 34709966 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling. Guan Z; Li C; Fan J; He D; Li L Sci Rep; 2016 Nov; 6():37085. PubMed ID: 27848972 [TBL] [Abstract][Full Text] [Related]
11. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals. Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth. Wang K; Sun Y; Guo C; Liu T; Fei X; Chang C Cell Death Dis; 2019 Apr; 10(5):339. PubMed ID: 31000693 [TBL] [Abstract][Full Text] [Related]
13. CD4 + T cells promote renal cell carcinoma proliferation via modulating YBX1. Wang Y; Wang Y; Xu L; Lu X; Fu D; Su J; Geng H; Qin G; Chen R; Quan C; Niu Y; Yue D Exp Cell Res; 2018 Feb; 363(1):95-101. PubMed ID: 29289594 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis. Guo C; Sun Y; Zhai W; Yao X; Gong D; You B; Huang CP; Zheng J; Chang C Cell Biosci; 2022 Nov; 12(1):185. PubMed ID: 36397101 [TBL] [Abstract][Full Text] [Related]
15. Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals. Song W; Li L; He D; Xie H; Chen J; Yeh CR; Chang LS; Yeh S; Chang C Cancer Lett; 2015 Nov; 368(1):71-78. PubMed ID: 26231735 [TBL] [Abstract][Full Text] [Related]
16. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling. Hu S; Li L; Yeh S; Cui Y; Li X; Chang HC; Jin J; Chang C Mol Oncol; 2015 Jan; 9(1):44-57. PubMed ID: 25135278 [TBL] [Abstract][Full Text] [Related]
18. Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals. Wang Y; Ou Z; Sun Y; Yeh S; Wang X; Long J; Chang C Oncogene; 2017 Mar; 36(12):1644-1654. PubMed ID: 27869170 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma. Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475 [TBL] [Abstract][Full Text] [Related]
20. Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors. Pak S; Kim W; Kim Y; Song C; Ahn H J Cancer Res Clin Oncol; 2019 Sep; 145(9):2293-2301. PubMed ID: 31401673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]